Breast Cancer Drug Tamoxifen Appears To Raise Risk Of Developing New Type Of Tumor, S
Breast cancer patients taking a long-term course of the estrogen-blocker tamoxifen, which has been used widely to prevent recurrences of hormone-sensitive breast cancer, might have four times the risk of developing "an uncommon but aggressive" new tumor that is not estrogen-sensitive, according to a new
More... |
All times are GMT -7. The time now is 06:23 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021